America’s Blood Centers (ABC) congratulates Karim Mikhail, B. Pharm, MSc, on his appointment to the role of Director of the FDA’s Center for Biologics Evaluation and Research (CBER). After serving as acting director, Mr. Mikhail’s permanent appointment provides important stability for CBER and for the nation’s blood and biotherapeutics communities. His leadership will help to advance innovation while fostering a collaborative regulatory environment that ensures the continued safety and availability of the nation’s blood supply.
“America’s Blood Centers congratulates Karim Mikhail on his appointment as Director of CBER,” said Kate Fry, ABC’s Chief Executive Officer. “His leadership will help to continue the collaborative partnership between FDA, ABC, and community blood centers, advancing innovation while supporting a regulatory environment that ensures a safe and available blood supply. We look forward to working closely with Mr. Mikhail and his team to advance policies that strengthen the nation’s blood supply and ensure patients continue to have access to safe, lifesaving blood products.”